Skip to content

Clinical trials

Choroidal Neovascularization trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Country / region: Italy Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20073
20083
20101
20121
20133
20142
20171
20191
20201
20211
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated5
Active, not recruiting1
Unknown status1
Withdrawn1
Recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
GlaxoSmithKline2
Ophthotech Corporation2
Pfizer2
AbbVie1
Allergan1
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo1
EyeBiotech Ltd.1
Federico II University1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization24
Macular Degeneration15
Wet Macular Degeneration6
Vision Disorders4
Eye Diseases3
Geographic Atrophy3
Retinal Diseases3
Myopia, Degenerative2
Retinal Degeneration2
Angioid Streaks1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.